Meningomyelocele; Spina bifida; Cleft spine; Neural tube defect (NTD); Birth defect - myelomeningocele
Myelomeningocele is a birth defect in which the backbone and spinal canal do not close before birth.
The condition is a type of spina bifida.
Normally, during the first month of a pregnancy, the two sides of the baby's spine (or backbone) join together to cover the spinal cord, spinal nerves and meninges (the tissues covering the spinal cord). The developing brain and spine at this point are called the neural tube. Spina bifida refers to any birth defect involving incomplete closure of the neural tube in the area of the spine.
Myelomeningocele is a neural tube defect in which the bones of the spine do not completely form. This results in an incomplete spinal canal. The spinal cord and meninges (the tissues covering the spinal cord) protrude from (stick out of) the child's back.
Myelomeningocele may affect as many as 1 out of every 4,000 infants.
The rest of spina bifida cases are most commonly:
Other congenital disorders or birth defects may also be present in a child with myelomeningocele. Hydrocephalus may affect as many as 90% of children with myelomeningocele. Other disorders of the spinal cord or musculoskeletal system may be seen, including syringomyelia (a fluid-filled cyst within the spinal cord) and hip dislocation.
The cause of myelomeningocele is unknown. However, low levels of folic acid in a woman's body before and during early pregnancy appear to play a part in this type of birth defect. The vitamin folic acid (or folate) is important for brain and spinal cord development.
If a child is born with myelomeningocele, future children in that family have a higher risk than the general population. However, in many cases, there is no family connection.
Some theorize that a virus may play a role, since there is a higher rate of this condition in children born in the early winter months. Research also indicates possible environmental factors such as radiation.
A newborn with this disorder will have an open area or a fluid-filled sac on the mid to lower back.
Symptoms may include:
Other signs and/or symptoms may include:
Prenatal screening can help diagnose this condition. During the second trimester, pregnant women can have a blood test called the quadruple screen. This test screens for myelomeningocele, Down syndrome, and other congenital diseases in the baby. Most women carrying a baby with spina bifida will have a higher-than-normal level of a protein called maternal alpha fetoprotein (AFP).
If the quadruple screen test is positive, further testing is needed to confirm the diagnosis.
Such tests may include:
Myelomeningocele can be seen after the child is born. A neurologic exam may show that the child has loss of nerve-related functions below the defect. For example, watching how the infant responds to pinpricks at various locations may reveal where the baby can feel the sensations.
Tests done on the baby after birth may include x-rays, ultrasound, CT, or MRI of the spinal area.
Genetic counseling may be recommended. In some cases where a severe defect is detected early in the pregnancy, abortion may be considered. However, intrauterine surgery to close the defect (before the baby is born) is offered in some highly specialized centers and appears to reduce the risk of some later complications.
After your baby is born, surgery to repair the defect is most often recommended within the first few days of life. Before surgery, the infant must be handled carefully to reduce damage to the exposed spinal cord. This may include special care and positioning, protective devices, and changes in the methods of handling, feeding, and bathing.
Children who also have hydrocephalus may need a ventriculoperitoneal shunt placed. This will help drain the extra fluid from the ventricles (in the brain) to the peritoneal cavity (in the abdomen).
Antibiotics may be used to treat or prevent infections such as meningitis or urinary tract infections.
Most children will require lifelong treatment for problems that result from damage to the spinal cord and spinal nerves.
Follow-up exams generally continue throughout the child's life. These are done to check the child's developmental progress and to treat any intellectual, neurological, or physical problems.
Visiting nurses, social services, support groups, and local agencies can provide emotional support and assist with the care of a child with a myelomeningocele who has significant problems or limitations.
Taking part in a spina bifida support group may be helpful for some people.
A myelomeningocele can most often be surgically corrected, but the affected nerves may still not function normally. (The higher the location of the defect on the baby's back, the more nerves will be affected.)
With early treatment, length of life is not severely affected. Kidney problems due to poor drainage of urine are the most common cause of death.
Most children with myelomeningocele will have normal intelligence. However, because of the risk of hydrocephalus and meningitis, more of these children will have learning problems and seizure disorders.
New problems within the spinal cord can develop later in life, especially after the child begins growing rapidly during puberty. This can lead to more loss of function as well as orthopedic problems such as scoliosis, foot or ankle deformities, dislocated hips, and joint tightness or contractures.
Many people with myelomeningocele primarily use a wheelchair.
Complications of spina bifida may include:
This list may not be all-inclusive.
Call your health care provider if:
Folic acid supplements may help reduce the risk of neural tube defects such as myelomeningocele. It is recommended that any woman considering becoming pregnant take 0.4 mg of folic acid a day. Pregnant women need 1 mg per day.
It is important to remember that folic acid deficiencies must be corrected before becoming pregnant, because the defects develop very early.
Prospective mothers may be screened to determine the amount of folic acid in their blood.
American College of Obstetricians and Gynecologists. ACOG Committee opinion no. 550: maternal-fetal surgery for myelomeningocele. Obstet Gynecol. 2013;121(1):218. PMID: 23262964 www.ncbi.nlm.nih.gov/pubmed/23262964.
Cohen AR, Couto J, et al. MMC Maternal-Fetal Management Task Force. Position statement on fetal myelomeningocele repair. Am J Obstet Gynecol. 2014;210(2):107-111. PMID: 24055581 www.ncbi.nlm.nih.gov/pubmed/24055581.
Kinsman SL, Johnston MV. Congenital anomalies of the central nervous system. In: Kliegman RM, Stanton BF, St Geme JW, Schor NF, eds. Nelson Textbook of Pediatrics. 20th ed. Elsevier; 2016:chap 591.
Wilson P, Stewart J. Meningomyelocele (spina bifida). In: Kliegman RM, Stanton BF, St Geme JW, Schor NF, eds. Nelson Textbook of Pediatrics. 20th ed. Elsevier; 2016:chap 715.BACK TO TOP
Review Date: 11/3/2015
Reviewed By: Kimberly G. Lee, MD, MSc, IBCLC, Associate Professor of Pediatrics, Division of Neonatology, Medical University of South Carolina, Charleston, SC. Review provided by VeriMed Healthcare Network. Also reviewed by David Zieve, MD, MHA, Isla Ogilvie, PhD, and the A.D.A.M. Editorial team.
The information provided herein should not be used during any medical emergency or for the diagnosis or treatment of any medical condition. A licensed medical professional should be consulted for diagnosis and treatment of any and all medical conditions. Call 911 for all medical emergencies. Links to other sites are provided for information only -- they do not constitute endorsements of those other sites. © 1997- 2016 A.D.A.M., Inc. Any duplication or distribution of the information contained herein is strictly prohibited.